(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma (NCT05907954)

🧪 Interventions in This Study

• Darovasertib (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (18 Sites)

• HonorHealth Research Institute — Scottsdale, Arizona
• Moores Cancer Center — La Jolla, California
• Stanford Cancer Institute — Palo Alto, California
• University of Miami — Miami, Florida
• The Cancer and Hematology Centers — Grand Rapids, Michigan
• Mayo Clinic Rochester — Rochester, Minnesota
• Northwell — Manhasset, New York
• Thomas Jefferson University — Philadelphia, Pennsylvania
• Sarah Cannon Research Institute — Nashville, Tennessee
• University of Texas Southwestern Medical Center — Dallas, Texas
• St. Vincent's Health Sydney — Sydney, New South Wales
• Alfred Health — Melbourne, Victoria
• Princess Margaret Cancer Centre — Toronto, Ontario
• Institute Curie — Paris,
• Charité - Universitätsmedizin Berlin — Berlin,
• Fondazione IRCCS Istituto Nazionale Tumori — Milan,
• Fondazione Policlinico Universitario Agostino Gemelli IRCCS — Rome,
• Leiden University Medical Center — Leiden,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Uveal Melanoma

• A Prospective Natural History Study in Uveal Melanoma — Boston, Massachusetts
• Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma — Tampa, Florida
• Psychoeducation for Uveal Melanoma — Los Angeles, California
• Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma — Tampa, Florida
• Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome — Columbus, Ohio

Explore by condition: All Uveal Melanoma clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.